Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2019
Sep. 30, 2018
Current assets:    
Cash $ 5,896,536 $ 3,759,509
Accounts receivable, net 4,027,235 3,972,632
Inventory, net 2,998,201 2,302,030
Prepaid expenses and other current assets 1,220,908 1,148,345
Total current assets 14,142,880 11,182,516
Plant and equipment, net 320,802 404,552
Deferred income taxes 8,570,150 8,543,758
Intangible assets, net 20,323,112 20,477,729
Goodwill 6,878,932 6,878,932
Other assets 776,178 965,152
Total assets 51,012,054 48,452,639
Current liabilities:    
Accounts payable 2,525,162 3,226,036
Accrued research and development costs 437,928 981,357
Accrued expenses and other current liabilities 2,472,422 2,465,657
Credit agreement, short-term portion (Note 7) 5,836,615 6,692,718
Unearned revenue   187,159
Total current liabilities 11,272,127 13,552,927
Credit agreement, long-term portion (Note 7) 2,717,934 2,701,570
Residual royalty agreement (Note 7) 2,341,522 1,753,805
Deferred income taxes 895,860 844,758
Deferred rent 210,594 88,161
Other liabilities 30,000 30,000
Total liabilities 17,468,037 18,971,221
Commitments and contingencies (Note 11)
Stockholders' equity:    
Preferred stock; no shares issued and outstanding at March 31, 2019 and September 30,2018
Common stock, par value $0.01 per share; 154,000,000 and 77,000,000 shares authorized, 64,968,184 and 57,468,660 shares issued and 62,784,480 and 55,284,956 shares outstanding at March 31, 2019 and September 30, 2018, respectively 649,682 574,687
Additional paid-in-capital 105,666,943 95,496,506
Accumulated other comprehensive loss (581,519) (581,519)
Accumulated deficit (64,384,484) (58,201,651)
Treasury stock, 2,183,704 shares, at cost (7,806,605) (7,806,605)
Total stockholders' equity 33,544,017 29,481,418
Total liabilities and stockholders' equity $ 51,012,054 $ 48,452,639